Related Experiment Videos
Multiple myeloma in remission complicated by bone marrow granulomas
R Gologan1, Camelia Dobrea, Loredana Popa
1Clinic of Hematology, Fundeni Clinical Institute, Bucharest, Romania. rgologan@hades.ro
Summary
Bone marrow granulomas in multiple myeloma patients can indicate toxoplasmosis. Treatment with azithromycin and pyrimethamine resolved granulomas and reduced antibody titers in a case study.
Area of Science:
- Hematology
- Infectious Diseases
- Histopathology
Background:
- Granulomas appear in 1-2% of biopsies, often linked to infections (50%) or hematologic disorders (25%) like multiple myeloma.
- Toxoplasmosis can induce bone marrow granulomas in immunocompromised individuals.
- Long-term remissions in multiple myeloma are occasionally observed.
Observation:
- A 56-year-old female with IgG(kappa) multiple myeloma, in remission for 5 years, presented with bone marrow epithelioid non-caseating granulomas.
- No clinical symptoms or abnormal lab tests were noted, and the patient had no relevant medication history.
- Serological tests were negative for other granuloma-inducing conditions, except for positive Toxoplasma gondii IgG antibodies.
Findings:
- Treatment with azithromycin and pyrimethamine led to the disappearance of bone marrow granulomas.
- Simultaneously, anti-Toxoplasma IgG antibody titers significantly decreased.
- This suggests a causal link between toxoplasmosis and granuloma formation in this multiple myeloma patient.
Implications:
- Bone marrow granulomas are diagnostic indicators for opportunistic infections.
- Bone marrow biopsy is crucial for diagnosing such conditions.
- Azithromycin shows promise in treating toxoplasmosis-induced granulomas.
- Comprehensive clinical, histopathological, and serological follow-up is essential for diagnosing granuloma etiology.